In human breast cancer cell lines with amplified ERBB2 expression, depletion of ERBB3 reduces cell proliferation to the same extent as depletion of ERBB2, while loss of ERBB1 (epidermal growth factor receptor (EGFR)) does not affect proliferation [4]. This evidence concerns the gene ERBB3 and breast cancer.